LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT) [Yahoo! Finance]
Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ:AMEX Investor Relations:
lixte.com/investor_information_02.php
Company Research
Source: Yahoo! Finance
months mean quiet trial work and the occasional conference slide deck. LIXTE Biotechnology Holdings ( NASDAQ:LIXT ) had other plans. Since June 2025, the company has rewritten its playbook, refreshing leadership, raising capital, securing scientific validation, and even moving part of its treasury into digital assets. If LB-100 is the scientific spark, then the corporate fire LIXTE is lighting around it may prove just as fascinating. The story really kicked off in June, when LIXTE decided to shuffle its leadership deck. Geordan Pursglove stepped up as Chairman and CEO, while Bas van der Baan, who had been wearing the CEO badge, slid into the role of Chief Scientific Officer. That wasn't a demotion, it was a refocus. Van der Baan went back to where his expertise shines: the science. Meanwhile, the board reconstituted its Scientific Advisory Committee and shifted headquarters to Boca Raton, Florida. On paper, it looked like housekeeping. In practice, it was a signal that LIXTE was rea
Show less
Read more
Impact Snapshot
Event Time:
LIXT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIXT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIXT alerts
High impacting Lixte Biotechnology Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
LIXT
News
- LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer TreatmentGlobeNewswire
- LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3GlobeNewswire
- LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition PlansGlobeNewswire
- Lixte Biotechnology (NASDAQ:LIXT) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions [Yahoo! Finance]Yahoo! Finance
LIXT
Sec Filings
- 11/28/25 - Form 25-NSE/A
- 11/25/25 - Form 8-K
- 11/12/25 - Form 10-Q
- LIXT's page on the SEC website